Syngen Biotech Co Ltd
TPEX:8279
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Syngen Biotech Co Ltd
TPEX:8279
|
TW |
|
First Citizens National Bank of Upper Sandusky OH
OTC:FSDK
|
US |
|
S
|
Sababa Security SpA
MIL:SBB
|
IT |
|
R
|
Regnon SA w likwidacji
WSE:REG
|
PL |
|
S
|
Sierra Nevada Gold Inc
ASX:SNX
|
US |
|
I
|
Issara Real Estate Investment Trust
SET:ISSARA
|
TH |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Syngen Biotech Co Ltd's stock price target?
Not Available
Syngen Biotech Co Ltd does not have any price targets made by Wall Street professionals.
What is the Gross Profit forecast for Syngen Biotech Co Ltd?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 19%. The projected CAGR for the next 2 years is -4%.
What is the Pre-Tax Income forecast for Syngen Biotech Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 29%. The projected CAGR for the next 2 years is 1%.
What is the Net Income forecast for Syngen Biotech Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Net Income has been 24%. The projected CAGR for the next 2 years is 2%.
